FAIRMOUNT FUNDS MANAGEMENT LLC exercised options at DAMORA THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 2 exercises
Filed: 2/12/2026ACC: 0001193125-26-047535
Director10% Owner
Since Feb 2026
+8.70M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
8.71M acquired · 8.71K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+5.81M
Price / share
—
Trade value
—
% of position
New position
2/9/2026
0.00→5.81M
Common Stock
Indirect
Shares
+2.90M
Price / share
—
Trade value
—
% of position
New position
2/9/2026
0.00→2.90M
Total
Net shares
+8.71M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/9/2026 | M · Option Exercise | +5.81M | — | — | New position | 0.00 | 5.81M |
| Common Stock Indirect | 2/9/2026 | M · Option Exercise | +2.90M | — | — | New position | 0.00 | 2.90M |
| Total | +8.71M | $0.00 | ||||||
Derivative Transactions2
Series C Preferred Stock
Indirect
Converts to
Common Stock
5.81M shares
Shares
−5.81K
Strike price
Held after
1.15K
Exercisable
—
2/9/2026
Series C Preferred Stock
Indirect
Converts to
Common Stock
2.90M shares
Shares
−2.90K
Strike price
Held after
574.00
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series C Preferred Stock Indirect | Common Stock5.81M shares | 2/9/2026 | M · Option Exercise | −5.81K | — | 1.15K | |
| Series C Preferred Stock Indirect | Common Stock2.90M shares | 2/9/2026 | M · Option Exercise | −2.90K | — | 574.00 |